Connecting linkedin

W1siziisimnvbxbpbgvkx3rozw1lx2fzc2v0cy9oyw1sew4td2lsbglhbxmvanbnl2jhbm5lci1kzwzhdwx0lwpvyi5qcgcixv0

Job

Vice President Clinical Development- Oncology

  • Location

    Redwood City, California

  • Sector:

    Executive Search, Life Sciences

  • Job type:

    Permanent

  • Salary:

    $300k+

  • Contact:

    Caroline Candela

  • Contact email:

    c.candela@hamlynwilliams.com

  • Salary high:

    0

  • Salary low:

    0

  • Job ref:

    CC- VP Clinical Development Oncology

  • Published:

    about 2 months ago

  • Expiry date:

    2020-06-20

  • Startdate:

    ASAP

Requirements:

  • Trained Medical Doctor M.D., Board certified or eligible in Oncology, Hematology/Oncology, or related field preferred.
  • 10+ years industry experience in clinical development required. Industry experience in intratumoral treatments preferred.
  • Excellent scientific record with experience in basic cancer research and/or oncology clinical trials within academic institutions or the pharmaceutical/biotech industry.
  • Desire and ability to effectively participate within multi-disciplinary teams.

 

Responsibilities:

  • Leads clinical strategy for developing oncology pipeline.
  • Designs and executes clinical studies and research plans in support of first-in-human and Phase I/II trials.
  • Contributes to selection of discovery compounds, design of development strategy and transition of compounds into early phase development.
  • Leads the interpretation of clinical results and makes appropriate recommendations in support of the overall strategy.
  • Contributes to the writing and review of reports submitted to regulatory agencies.
  • Builds relationships with key opinion leaders and principal investigators.
  • Contribute to corporate strategic and organizational initiatives.
  •  Leads and oversees the tactical development and strategic definition of clinical study programs, including protocol writing, interpretation of clinical data, and literature reviews.
  • Ensures that all clinical studies are in keeping with approved timelines, with potential obstacles identified and solutions implemented to avoid delays in clinical study execution.